Gastric bypass up-regulates insulin signaling pathway

Nutrition

Volumn 27, Issue 1, 2011, Pages 73-80

  Bonhomme, Sandra ^a,b   Guijarro, Ana ^a   Keslacy, Stefan ^a,c   Goncalves, Carolina G ^a,e   Suzuki, Susumu ^a   Chen, Chung ^d   Meguid, Michael M ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c SYRACUSE UNIVERSITY   (United States)

^d SYRACUSE UNIVERSITY   (United States)

^e POSITIVO UNIVERSITY   (Brazil)

Author keywords

Adiponectin; Diabetes; Gastric bypass; Insulin receptor; Insulin receptor substrates

Indexed keywords

ADIPONECTIN; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; FOOD INTAKE; LIVER; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; ROUX Y ANASTOMOSIS; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; STOMACH BYPASS; UPREGULATION; WEIGHT REDUCTION;

ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; ENERGY INTAKE; GASTRIC BYPASS; GLUCOSE TRANSPORTER TYPE 4; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; LIVER; MALE; MUSCLE, SKELETAL; OBESITY; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; UP-REGULATION; WEIGHT LOSS;

RATTUS;

EID: 78649962042     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2010.08.005     Document Type: Article

References (36)

1. Buchwald H., Avidor Y., Braunwald E., Jensen M.D., Pories W.J., Fahrbach K., Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004, 292:1724-1737.
2. Pories W.J., Swanson M.S., MacDonald K.G., Long S.B., Morris P.G., Brown B.M., et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995, 222:339-350. discussion 350-352.
3. Rubino F., Gagner M., Gentileschi P., Kini S., Fukuyama S., Feng J., Diamond E. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 2004, 240:236-242.
4. Sjostrom L., Narbro K., Sjostrom C.D., Karason K., Bo Larsson B., Wedel H., et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007, 357:741-752.
5. Pories W.J., Albrecht R.J. Etiology of type II diabetes mellitus: role of the foregut. World J Surg 2001, 25:527-531.
6. Guijarro A., Osei-Hyiaman D., Harvey-White J., Kunos G., Suzuki S., Nadtochiy S., et al. Sustained weight loss after Roux-en-Y gastric bypass is characterized by down regulation of endocannabinoids and mitochondrial function. Ann Surg 2008, 247:779-790.
7. Schauer P.R., Burguera B., Ikramuddin S., Cottam D., Gourash W., Hamad G., et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003, 238:467-484. discussion 484-485.
8. Pender C., Goldfine I.D., Tanner C.J., Pories W.J., MacDonald K.G., Havel P.J., et al. Muscle insulin receptor concentrations in obese patients post bariatric surgery: relationship to hyperinsulinemia. Int J Obes Relat Metab Disord 2004, 28:363-369.
9. Luo R.Z., Beniac D.R., Fernandes A., Yip C.C., Ottensmeyer F.P. Quaternary structure of the insulin-insulin receptor complex. Science 1999, 285:1077-1080.
10. Pessin J.E., Saltiel A.R. Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 2000, 106:165-169.
11. McCarthy A.M., Elmendorf J.S. GLUT4's itinerary in health and disease. Indian J Med Res 2007, 125:373-388.
12. Pessin J.E., Thurmond D.C., Elmendorf J.S., Coker K.J., Okada S. Molecular basis of insulin-stimulated GLUT4 vesicle trafficking. J Biol Chem 1999, 274:2593-2596.
13. Bhattacharya S., Dey D., Roy S.S. Molecular mechanism of insulin resistance. J Biosci 2007, 32:405-413.
14. Valverde A.M., Burks D.J., Fabregat I., Fisher T.L., Carretero J., White M.F., Benito M. Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes. Diabetes 2003, 52:2239-2248.
15. Guijarro A., Suzuki S., Chen C., Kirchner H., Middleton F.A., Nadtochiy S., et al. Characterization of weight loss and weight regain mechanisms after Roux-en-Y gastric bypass in rats. Am J Physiol Regul Integr Comp Physiol 2007, 293:R1474-R1489.
16. Meguid M.M., Ramos E.J., Suzuki S., Xu Y., George Z.M., Das U.N., et al. A surgical rat model of human Roux-en-Y gastric bypass. J Gastrointest Surg 2004, 8:621-630.
17. Quinn R. Comparing rat's to human's age: how old is my rat in people years?. Nutrition 2005, 21:775-777.
18. Xu Y., Ohinata K., Meguid M.M., Marx W., Tada T., Chen C., et al. Gastric bypass model in the obese rat to study metabolic mechanisms of weight loss. J Surg Res 2002, 107:56-63.
19. Suzuki S., Ramos E.J., Goncalves C.G., Chen C., Meguid M.M. Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model. Surgery 2005, 138:283-290.
20. Meguid M.M., Glade M.J., Middleton F.A. Weight regain after Roux-en-Y: a significant 20% complication related to PYY. Nutrition 2008, 24:832-842.
21. Ide T., Shimano H., Yahagi N., Matsuzaka T., Nakakuki M., Yamamoto T., et al. SREBPs suppress IRS-2-mediated insulin signalling in the liver. Nat Cell Biol 2004, 6:351-357.
22. Paz K., Liu Y.F., Shorer H., Hemi R., LeRoith D., Quan M., et al. Phosphorylation of insulin receptor substrate-1 (IRS-1) by protein kinase B positively regulates IRS-1 function. J Biol Chem 1999, 274:28816-28822.
23. Withers D.J., Gutierrez J.S., Towery H., et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 1998, 391:900-904.
24. Samuel V.T., Liu Z.X., Qu X., Burks D.J., Ren J.M., Previs S., et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 2004, 279:32345-32353.
25. Andreelli F., Laville M., Ducluzeau P.H., Vega N., Vallier P., Khalfallah Y., et al. Defective regulation of phosphatidylinositol-3-kinase gene expression in skeletal muscle and adipose tissue of non-insulin-dependent diabetes mellitus patients. Diabetologia 1999, 42:358-364.
26. Ducluzeau P.H., Perretti N., Laville M., Andreelli F., Vega N., Riou J.P., Vidal H. Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes. Diabetes 2001, 50:1134-1142.
27. Suzuki R., Tobe K., Aoyama M., Inoue A., Sakamoto K., Yamauchi T., et al. Both insulin signaling defects in the liver and obesity contribute to insulin resistance and cause diabetes in Irs2(-/-) mice. J Biol Chem 2004, 279:25039-25049.
28. Kerouz N.J., Horsch D., Pons S., Kahn C.R. Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J Clin Invest 1997, 100:3164-3172.
29. Kubota N., Terauchi Y., Tobe K., Yano W., Suzuki R., Ueki K., et al. Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus. J Clin Invest 2004, 114:917-927.
30. Jbilo O., Ravinet-Trillou C., Arnone M., Buisson I., Bribes E., Péleraux A., et al. The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance. FASEB J 2005, 19:1567-1569.
31. Engl J., Sturm W., Sandhofer A., Kaser S., Tschoner A., Tatarczyk T., et al. Effect of pronounced weight loss on visceral fat, liver steatosis and adiponectin isoforms. Eur J Clin Invest 2008, 38:238-244.
32. Linscheid P., Christ-Crain M., Stoeckli R., Reusch C.E., Lutz T.A., Müller B., Keller U. Increase in high molecular weight adiponectin by bariatric surgery-induced weight loss. Diabetes Obes Metab 2008, 10:1266-1270.
33. Kadowaki T., Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005, 26:439-451.
34. Yamamoto Y., Hirose H., Saito I., Nishikai K., Saruta T. Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population. J Clin Endocrinol Metab 2004, 89:87-90.
35. Maeda N., Shimomura I., Kishida K., Nishizawa H., Matsuda M., Nagaretani H., et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002, 8:731-737.
36. Nawrocki A.R., Rajala M.W., Tomas E., Pajvani U.B., Saha A.K., Trumbauer M.E., et al. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 2006, 281:2654-2660.